Enveric Biosciences Inc
(ENVB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1998 | 12-1997 | 12-1996 | 12-1995 | 12-1994 | |
| Sales | 1,680 | 2,780 | 2,020 | 1,230 | 180 |
| Cost of Goods | 130 | N/A | N/A | N/A | N/A |
| Gross Profit | 1,540 | 2,780 | 2,020 | 1,230 | 180 |
| Operating Expenses | 3,610 | 3,700 | 2,540 | 620 | 180 |
| Operating Income | -1,930 | -920 | -520 | 610 | N/A |
| Interest Expense | 80 | 20 | 10 | 30 | 30 |
| Other Income | -3,740 | -3,710 | -24,550 | -3,750 | 0 |
| Pre-tax Income | -5,750 | -4,650 | -25,080 | -3,170 | -30 |
| Income Tax | 30 | 60 | 310 | 60 | N/A |
| Net Income Continuous | -5,780 | -4,710 | -25,390 | -3,230 | -30 |
| Net Income | $-5,790 | $-4,710 | $-25,390 | $-3,240 | $-1,190 |
| EPS Basic Total Ops | -4,166,522.00 | -4,158,441.00 | -2,084,961.00 | N/A | N/A |
| EPS Basic Continuous Ops | -4,159,326.00 | -4,158,441.00 | -2,084,961.00 | N/A | N/A |
| EBITDA(a) | $-1,810 | $-520 | $-390 | $680 | $20 |